| Literature DB >> 33640188 |
Manuel Martínez-Gómez1, Joan Andrés Ramírez-Ospina2, Juan David Ruiz-Restrepo2, Margarita María Velásquez-Lopera2.
Abstract
Pyoderma gangrenosum associated to the use of cocaine/levamisole is a rare condition associated to their consumption. Cocaine use is frequent in Colombia, and the substance is contaminated with levamisole, an anthelmintic that increases the psychotropic effects and enhances its side effects. We present three clinical cases of patients with ulcerated lesions, in which the diagnosis was pyoderma gangrenosum secondary to the use of cocaine contaminated with levamisole. This called the attention of the health staff to investigate the abuse of substances in gangrenous pyoderma and also evidence that the interruption of consumption was the basis of management.Entities:
Keywords: Cocaine; Levamisole; Pyoderma gangrenosum
Mesh:
Substances:
Year: 2021 PMID: 33640188 PMCID: PMC8007549 DOI: 10.1016/j.abd.2020.06.014
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Figure 1(A and B). Deep ulcer with irregular, well-defined borders, piercing, mild perilesional erythema, clean fundus, granular, without exudation on the left gluteus.
Figure 2(A and C). Erythematosus nodules ulcers with violet brownish, well-defined, slightly raised borders, cribriform in the middle on legs and hands. (B) Violet papule with central vesiculation on the back dorsum.
Figure 3(A) Ulcer with abundant neutrophilic infiltrate on the papillary and reticular dermis. Box: detail of cellular component (arrow). (B) Dense perivascular inflammatory infiltrate of neutrophils. Box: detail of cellular component (arrow).
Figure 4(A and B). Superficial ulcers, round in shape, well-defined, raised and slightly violet borders on both legs.
Figure 5Laboratorial exams in patients with pyoderma gangrenosum related to cocaine. (X axis, number of patients; Y axis, altered paraclinical). ANAs, antinuclear antibodies; ANCAS, antineutrophil cytoplasmic antibodies, TKP, total kinase protein, AntiPR3, proteinase 3; AntiMPO, myeloperoxidase; Lupus A, lupus anticoagulant; LDH, lactic dehydrogenase; CRP, C reactive protein; ESR, erythrocyte sedimentation rate.
Cases of pyoderma gangrenosum associated with cocaine or cocaine/levamisole use reported in the literature.
| Nº | Authors | Age and sex | Time of consume | Time to onset PG | Localization | Rechallengea | Vasculitis | Systemic symptoms | Autoantibodies | Treatment | Cocaine level |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Friedman et al. (2005) | 27 F | NR | NR | Face, legs, arms and back. Septum destruction, ethmoidal and maxillary sinusitis | Yes | No | No | ANAs+ 1:640, p-ANCAS + against PR3 | NR | Yes |
| 2 | E. Roche et al. (2008) | 30 M | 2 years | 3 months | Initially back, later trunk and limbs | Yes | No | No | No | Cyclosporine, topical methotrexate, tacrolimus, and infliximab after interrupting cocaine consumption | Yes |
| 3 | E. Roche et al. (2008) | 37 M | 10 years | 4 months | Back, upper third of the arms, and cheek | Yes | Yes | No | No | Infliximab, topical tacrolimus, associated with cocaine abstinence | No |
| 4 | Camilla Bezerra da Cruz Maia et al. (2012) | 27 F | 10 years | 5 years | Left half-face and inferior members. Hard palate and nasal septum destruction | Yes | No | No | No | Azathioprine and prednisone resulted satisfactory with partial healing of the face | No |
| 5 | D. Jimenez-Gallo et al. (2013) | 54 F | 5 years | 2 months | Both legs. Saddlenose nasal deformity associated with oronasal fistula | Yes | No | Retiform purpura and lung involvement | p-ANCAS+ 1:80 for elastase and ANAs 1:40 | Cyclophosphamide bolus | Yes |
| 6 | Phillip J. Keith et al. (2014) | 51 F | NR | 2 months | Face, abdomen, back, thigh and pubis | Yes | No | No | P-ANCA+ > 1:640, ANAs+, AL+, ACL+ | Prednisone and cocaine abstinence | No |
| 7 | Haneol S. Jeong et al. (2015) | n = 8; ages and sex NR | NR | 1 week to 4 weeks (median: 1 week) | Lower limbs (n = 8), upper limbs (n = 6), trunk (n = 3), face (n = 3) | Yes | n = 5 | Retiform purpura (n = 3). Artrhalgias (n = 1) | ACL+ (n = 5), AL+ (n = 3), B2GP+ (n = 4) p-ANCA+ (n = 7), anti PR3+ (n = 4) y anti-MPO+ (n = 7), ANAs+ (n = 3) and FR+ (n = 1) | Prednisone were administered in 6 of 8 patients. Gentle wound care and cocaine avoidance in all patients with improvement | Yes |
| 8 | Carola Baliu-Piqué et al. (2016) | 40 F | NR | 2 weeks | Breast, hips, upper and lower extremities | Yes | No | No | No | Methylprednisolone bolus, cyclosporine, infliximab, and mycophenolic acid | Yes |
| 9 | Ricardo Ruiz-Villaverde et al. (2016) | 38 M | NR | NR | Armpits, chest, pubis, and lumbar region | Yes | No | No | No | Prednisone | Yes |
| 10 | Rahul Sehgal et al. (2017) | 53 F | NR | 6 months | On the upper back. Ulceration of bilateral nasal passages and nasal septum perforation | Yes | No | Right-sided multifocal pneumonitis and mild reactive lymphadenopathy. | No | Intralesional triamcinolone, local wound care, prednisone, dapsone, topical tacrolimus, cyclosporine, and cocaine discontinuation, resulting in gradual improvement | Yes |
| 11 | Ester Moreno-Artero et al. (2018) | 37 M | NR | 4 years | Cheeks and right gluteal area | Yes | No | No | c-ANCAS + against PR3 and AL+ | NR | Yes |
| 12 | Ester Moreno-Artero et al. (2018) | 34 F | NR | 20 days | Both hands, lower back, and lower limbs | Yes | No | No | p-ANCAs + against elastase | NR | Yes |
| 13 | Ester Moreno-Artero et al. (2018) | 43 M | 3 years | 6 months | Face, trunk, and lower limbs | Yes | No | No | ANCAs + against elastase | NR | Yes |
| 14 | Andrea Estébaneza et al. (2020) | 40 F | NR | 6 months | Back, chin, and retroauricular area, destruction of the nasal septum and the lateral maxillary sinus wall | Yes | No | Left posterior perirenal and pararenal esteril abscess | No | Corticosteroids and cessation of cocaine use through a rehabilitation program, skin lesions and kidney abscess resolved. | No |
| 15 | Andrea Estébaneza et al. (2020) | 51 M | NR | NR | Right Achilles tendon lesion | Yes | Yes | No | No | Prednisone and cocaine consumption were temporarily interrupted | Yes |
| 16 | Andrea Estébaneza et al. (2020) | 54 M | NR | 2 weeks | Back | Yes | No | No | ANAs+ (title 1/320). | Corticosteroid | Yes |
aRecurred with repeat cocaine use.
F, female; M, male; NR, not registered; ANA, antinuclear antibody; p-ANCA, perinuclear anti-neutrophil cytoplasmic antibodies; PR3, Antiproteinase-3 antibody; AL, lupus anticoagulant; ACL, cardiolipin antibody; B2GP, beta-2 glycoprotein; anti-MPO, antimyeloperoxidase; FR, rheumatoid factor; c-ANCA, cytoplasmic antineutrophil cytoplasmic antibody.